Contraception
Fallopian Tube Device Gets High Marks From Patients
Published in Women's Health Weekly, April 19th, 2001
Conceptus, Inc. (CPTS), developer of the StopTM (Selective Tubal Occlusion Procedure) non-surgical permanent birth control device for women, announced that the first interim review of data from the Stop pivotal trial found a reduction in average procedure time, an increase in the rate of placement in both fallopian tubes (bilateral placement), and a decrease in the adverse event rate, when compared with interim data from the Phase II study as of March 23, 2001.
At the 10th Annual Congress of the International Society for Gynecologic Endoscopy (ISGE), held in Chicago, Illinois, John Kerin, MD, with the Ashford Community Hospital, Adelaide, Australia, and a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Chest Pain
Researchers Study Possible Genetic Link To Dysfunctional Coronary Arteries In Women - Disease Associations
Study Uncovers Bias Toward Men In Treating Heart Disease - Breast Cancer
Risk Lower Than Women Think; Statistics By Age, Ethnicity Give More Realistic Picture - Genital Herpes
HSV2 Grows Up: Boomer Women Continue To Suffer Physical, Psychological Effects - HIV Transmission
Women Account For Increasing Share Of New Infections - Obstetrics
Home Care Or Hospital: Differences For Women Experiencing Pre-Term Labor - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
